Company: CERO
Filing Date: 2025-08-15
Form Type: NT 10-Q
Source: 0001213900-25-077436
Chunk: 1

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-08-15
Form: NT 10-Q
Chunk 1
---
 the subject quarterly report or transition report on Form 10-Q or subject distribution    
 report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and            |                                                                                       |
|   | -c | The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.                                      |                                                                                       |

<div align='center'>PART III — NARRATIVE</div>

State below in reasonable detail the reasons why
Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed
time period.

As reported in the Current Report on Form 8-K
filed on April 22, 2025 for CERo Therapeutics Holdings, Inc. (the “Company”), the Company entered into a securities purchase
agreement with certain investors (the “SPA”) and pursuant to such SPA, the Company has received marketable securities as payment
of a portion of the purchase price of the shares of Series D Preferred Stock issued by the Company pursuant thereto. Such marketable securities
consist of shares of convertible preferred stock of another publicly-traded company. The Company’s management and accounting personnel
are finalizing the valuation and accounting treatment for the marketable securities and transactions related thereto. As a result of the
pending finalization of these items, there will be a delay in the Company’s ability to complete and file its Quarterly Report on
Form 10-Q for the three-months ended June 30, 2025 (the “Quarterly Report”) by the August 14, 2025 filing date applicable
to smaller reporting companies without unreasonable effort and expense. The Company anticipates that it will file the Quarterly Report
no later than the fifth calendar day following the prescribed filing date.

<div align='center'>PART IV — OTHER INFORMATION</div>

| (1) | Name and telephone number of person to contact in regard to this notification. |

| Andrew Kucharchuk |     |        650 |     | 407-2376          |
| (Name)            |     | -Area Code |     | -Telephone Number |

| (2) | Have all other periodic reports required under Section 13 or                                                                           
 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act